Home LiteratureArticle Details
PMID: 15985559 Published · ppublish English Clinical Trial Journal Article Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Long term follow up of patients treated for Helicobacter pylori infection.

Gut ·Vol. 54 ·No. 11 ·2005-11-00 ·Pages 1536-40

Mera R, Fontham ET, Bravo LE, Bravo JC, Piazuelo MB, Camargo MC, Correa P

Abstract

Helicobacter pylori infection induces progressive inflammatory changes in the gastric mucosa that may lead to gastric cancer. Understanding long term effects resulting from the cure of this infection is needed to design cancer prevention strategies. A cohort of 795 adults with preneoplastic gastric lesions was randomised to receive anti-H pylori treatment and/or antioxidants. At the end of six years of intervention, those who did not receive anti-H pylori treatment were offered it. Gastric biopsies were obtained at baseline, and at 3, 6, and 12 years. A histopathology score was utilised to document changes in gastric lesions. Non-linear mixed models were used to estimate the cumulative effect of H pylori clearance on histopathology scores adjusted for follow up time, interventions, and confounders. Ninety seven per cent of subjects were H pylori positive at baseline, and 53% were positive at 12 years. Subjects accumulated 1703 person years free of infection. A multivariate model showed a significant regression in histopathology score as a function of the square of H pylori negative time. Subjects who were H pylori negative had 14.8% more regression and 13.7% less progression than patients who were positive at 12 years (p = 0.001). The rate of healing of gastric lesions occurred more rapidly as years free of infection accumulated, and was more pronounced in less advanced lesions. Preneoplastic gastric lesions regress at a rate equal to the square of time in patients rendered free of H pylori infection. Our findings suggest that patients with preneoplastic gastric lesions should be treated and cured of their H pylori infection.

MeSH Terms
Acute Disease Adult Aged Anti-Bacterial Agents Antioxidants/therapeutic use Chronic Disease Disease Progression Drug Therapy, Combination/therapeutic use Female Follow-Up Studies Gastritis/microbiology,pathology Helicobacter Infections/complications,drug therapy Helicobacter pylori Humans Male Middle Aged Precancerous Conditions/microbiology,pathology Recurrence Stomach Neoplasms/microbiology,pathology,prevention & control
Chemicals
Anti-Bacterial Agents Antioxidants
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Mera R
Department of Pathology, Louisiana State University Health Sciences Center, 1901 Perdido St, New Orleans, LA 70112, USA.
Fontham E T H
Bravo L E
Bravo J C
Piazuelo M B
Camargo M C
Correa P
References (26)
26 references, click to expand
  1. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy.
    J Natl Cancer Inst. 2000 Dec 6;92(23):1881-8 PMID: 11106679
  2. Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study.
    Gastroenterology. 2000 Jul;119(1):7-14 PMID: 10889149
  3. Helicobacter pylori genotypes may determine gastric histopathology.
    Am J Pathol. 2001 Feb;158(2):647-54 PMID: 11159201
  4. Improvement in atrophic gastritis and intestinal metaplasia in patients in whom Helicobacter pylori was eradicated.
    Ann Intern Med. 2001 Mar 6;134(5):380-6 PMID: 11242498
  5. Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading.
    Aliment Pharmacol Ther. 2002 Jul;16(7):1249-59 PMID: 12144574
  6. Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: a 5-year prospective study of patients with atrophic gastritis.
    Aliment Pharmacol Ther. 2002 Aug;16(8):1449-56 PMID: 12182744
  7. Alteration of histological gastritis after cure of Helicobacter pylori infection.
    Aliment Pharmacol Ther. 2002 Nov;16(11):1923-32 PMID: 12390101
  8. A five-year follow-up study on the pathological changes of gastric mucosa after H. pylori eradication.
    Chin Med J (Engl). 2003 Jan;116(1):11-4 PMID: 12667379
  9. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial.
    JAMA. 2004 Jan 14;291(2):187-94 PMID: 14722144
  10. Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer.
    Int J Cancer. 2004 Mar10;109(1):138-43 PMID: 14735480
  11. Helicobacter pylori eradication and gastric preneoplastic conditions: a randomized, double-blind, placebo-controlled trial.
    Cancer Epidemiol Biomarkers Prev. 2004 Jan;13(1):4-10 PMID: 14744726
  12. A model for gastric cancer epidemiology.
    Lancet. 1975 Jul 12;2(7924):58-60 PMID: 49653
  13. Cigarette smoking and bronchial carcinoma: dose and time relationships among regular smokers and lifelong non-smokers.
    J Epidemiol Community Health. 1978 Dec;32(4):303-13 PMID: 744822
  14. Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data.
    Int J Cancer. 1985 Feb 15;35(2):173-7 PMID: 3871738
  15. Gastric precancerous process in a high risk population: cohort follow-up.
    Cancer Res. 1990 Aug 1;50(15):4737-40 PMID: 2369748
  16. Intestinal metaplasia types and the risk of gastric cancer: a cohort study in Slovenia.
    Int J Cancer. 1994 May 1;57(3):324-9 PMID: 8168991
  17. Long-term consequences of Helicobacter pylori eradication.
    Scand J Gastroenterol Suppl. 1994;205:38-44 PMID: 7863240
  18. Long-term sequelae of Helicobacter pylori gastritis.
    Lancet. 1995 Jun 17;345(8964):1525-8 PMID: 7791437
  19. Long-term course and consequences of Helicobacter pylori gastritis. Results of a 32-year follow-up study.
    Scand J Gastroenterol. 1996 Jun;31(6):546-50 PMID: 8789892
  20. Two- to four-year histological follow-up of gastric mucosa after Helicobacter pylori eradication.
    J Pathol. 1999 May;188(1):24-9 PMID: 10398136
  21. Helicobacter pylori eradication and antral intestinal metaplasia--two years follow-up study.
    J Physiol Pharmacol. 1997 Sep;48 Suppl 4:115-22 PMID: 9440062
  22. Unsuccessful treatment results in survival of less virulent genotypes of Helicobacter pylori in Colombian patients.
    Am J Gastroenterol. 2000 Feb;95(2):564-6 PMID: 10685783
  23. Effect of Helicobacter pylori eradication on gastritis in relation to cagA: a prospective 1-year follow-up study.
    Gastroenterology. 1997 Jul;113(1):25-30 PMID: 9207258
  24. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994.
    Am J Surg Pathol. 1996 Oct;20(10):1161-81 PMID: 8827022
  25. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer.
    Cancer Epidemiol Biomarkers Prev. 1997 Aug;6(8):639-42 PMID: 9264278
  26. Gastric dysplasia: the Padova international classification.
    Am J Surg Pathol. 2000 Feb;24(2):167-76 PMID: 10680883
Article Info
Journal
Gut
Abbr.
Gut
ISSN
0017-5749
Published
2005-11-00
Epub
2005-00-28
Pages
1536-40
Language
English
Region
England
NLM ID
2985108R
PMCID
PMC1462952
Subset
IM
Grants
NCI NIH HHS · P01 CA028842 · United States
NCI NIH HHS · P01CA028842 · United States
Corrections
CommentIn
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]